All In Biotech

Free tool

FAERS Monitor: Zerviate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208694 or its brand name (Zerviate, Cetirizine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

43,309

Serious

34,381

79% of reports

Hospitalization

15,619

Death reported

5,083

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue5,853
  • drug ineffective5,324
  • pain5,158
  • rash5,124
  • off label use4,634
  • dyspnoea4,628
  • pruritus4,543
  • arthralgia4,078
  • pyrexia3,959
  • hypersensitivity3,788
  • headache3,709
  • nausea3,701
  • joint swelling3,614
  • swelling3,606
  • abdominal discomfort3,550

Reports by year received

View as table
YearReports
20044
20059
200634
20071
200814
2009149
201051
2011139
2012575
2013732
20141,189
20151,657
20162,030
20172,063
20182,874
20193,253
20203,691
20214,135
20223,599
20233,845
20244,820
20255,075
20263,370

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,010,850 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
swellingSignal3,60619.418.860,834
joint swellingSignal3,61415.014.545,912
abdominal discomfortSignal3,55010.510.130,022
hypersensitivitySignal3,78810.19.830,671
pruritusSignal4,5435.85.618,150
rashSignal5,1245.85.620,360
pyrexiaSignal3,9595.65.415,067
arthralgiaSignal4,0784.84.712,391
painSignal5,1584.14.012,366
dyspnoeaSignal4,6284.03.910,588
fatigueSignal5,8533.73.611,721
headacheSignal3,7092.92.84,676
off label useSignal4,6342.62.54,646
nauseaSignal3,7012.32.22,740
drug ineffective5,3242.01.92,683

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.